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Pigmented villonodular synovitis does
not influence the outcome following
cementless total hip arthroplasty using
ceramic-on-ceramic articulation: a case-
control study with middle-term follow-up
Chi Xu1, Heng Guo1,2, Kerri L. Bell3, Feng-Chih Kuo4* and Ji-Ying Chen1*
Abstract
Background: Pigmented villonodular synovitis (PVNS) is a relatively rare, locally aggressive, and potentially recurrent
synovial disease of large joints. The purpose of this study was to investigate (1) the disease recurrence rate and (2)
the treatment outcomes including Harris hip scores, complications, and revision following cementless total hip
arthroplasty (THA) with ceramic-on-ceramic (CoC) articulation in patients with PVNS.
Methods: Twenty-two patients (14 females and 8 males) with histologically confirmed PVNS underwent cementless
THA using CoC bearings between 2000 and 2013. Three patients with less than 5-year follow-up were excluded.
The mean age was 35.2 years (range, 22–58 years) with a mean follow-up of 8.6 years (range, 6.9–10.8 years). A
control group was matched in a 2:1 ratio with the PVNS group for age, sex, body mass index (BMI), year of surgery,
and American Society of Anesthesiologists score (ASA). Postoperative outcome variables included disease
recurrence, Harris Hip Scores (HHS) at the latest follow-up, complications (dislocation, squeaking, ceramic fracture),
and any-cause revision. A Kaplan-Meier implant survivorship curve with 95% confidence interval (CI) of the two
groups was generated.
Results: No recurrence of PVNS was noted in the follow-up period. The HSS in the PVNS group was 92.6 ± 5.5,
which was similar to the control group (93.4 ± 4.6, p = 0.584) at the last follow-up visit. No patients sustained
dislocation, osteolysis, or any ceramic fracture within the study duration. One patient in the PVNS group had a
complication of squeaking, but did not require revision. Another patient in the PVNS group underwent revision
surgery due to aseptic loosening. There was no significant difference in revision rates between the two groups
(p = 1.000). The implant survivorship free of any revision was 90.0% (95% CI, 73.2% to 100%) in the PVNS group and
92.5% (95% CI, 82.6% to 100%) in the control group at 10 years (p = 0.99).
Conclusions: For young and active patients with end-stage PVNS of the hips, cementless THA using CoC bearing
has similar functional outcome scores, a low complication rate, and similar implant survivorship compared to the
control group.
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Background
Pigmented villonodular synovitis (PVNS) of the hip is a
benign, but potentially locally aggressive and recurrent
monoarticular disorder which typically affects large
joints; 80% of the time it involves the knee, while hips
are affected only 15% of the time [1]. It is an uncommon
disorder, with an estimated incidence of 1.8 per million
patients [2–4]. It is characterized by a proliferation of
synovial villi and nodules within joint spaces, bursa, or
tendon sheaths [5]. As synovial hyperplasia pervades the
hip, it causes discomfort by narrowing the joint space,
leading to sharp hip pain [3]. A radical synovectomy,
whether via arthroscopy or an open surgical approach,
has been utilized as a treatment for hips with mild cartil-
age degeneration. However, in cases demonstrating se-
vere end-stage arthritis due to disease progression, total
hip arthroplasty (THA) plus radical synovectomy is the
preferred treatment choice [6].
PVNS of the hip commonly affects patients in their
third or fourth decade of life [7]. A recent study re-
ported that complications and revision rates following
THA are high in patients with PVNS due to the youth
of patients and the utilization of conventional polyethyl-
ene [8]. Given the likelihood of requiring revision
surgery for younger patients undergoing THA, the con-
cern of implant survivorship, wear performance, and
functionality should be considered when selecting a
fixation technique and a bearing surface. As one of the
most popular combinations, cementless implants with
ceramic-on-ceramic (CoC) articulation have shown po-
tential benefits in young patients, as they have low wear
rates with excellent clinical outcomes [9–13]. Although
several studies have suggested acceptable outcomes with
a low recurrence rate following THA in PVNS patients
during the long-term follow-up [1, 6, 8, 14], there is a
paucity of data focusing on cementless implants using
CoC articulation in these patients. Moreover, these pre-
vious studies were limited by small sample sizes and
lacked a control group in their evaluation of outcomes.
Therefore, the purpose of this study was to investigate
the disease recurrence rate and the treatment outcomes
including Harris Hip Scores, complications, and revision
rates following cementless THA with CoC articulation
in patients with PVNS.
Materials and methods
Study cohort
After the Institutional Review Board approval, we retro-
spectively reviewed 22 patients with a diagnosis of PVNS
of the hip who underwent cementless THA with CoC
articulation between 2000 and 2013. The diagnosis of
diffuse PVNS was made for all patients by histological
confirmation in accordance with Jaffé’s classification
[15]. Three patients with follow-up less than 5 years
were excluded. In all, 19 patients with a mean follow-up
of 8.6 years (range, 6.9 to 10.8 years) were enrolled in
this study (Table 1). There were 7 males and 12 females
with a mean age of 35.2 (range, 22 to 58) years.
These patients were matched with a control group of
patients; the controls were patients diagnosed with
either osteoarthritis of the hip or femoral head necrosis
who underwent cementless THA using CoC articulation.
The patients in the control group were matched with
the patients in the study group for age (± 5 years), sex,
body mass index (BMI, ± 1 kg/m2), year of surgery
(within 1 year), and American Society of Anesthesiolo-
gists Score (ASA) (± 1) in a 2:1 ratio.
Clinical and radiographic features of patients with PVNS
before THA
The mean time from onset of symptoms to arthroplasty
was 2.9 years (range, 1–6.2 years). All patients presented
hip pain as the primary complaint. One patient, a
28-year-old woman (case 13), was diagnosed with Crowe
Type III developmental hip dysplasia. Four patients had
hip trauma before THA, while another patient had
undergone internal fixation with cannulated screws for a
fracture of the femoral neck. Five patients had under-
gone arthroscopic synovectomy before THA; the mean
time from the last synovectomy to THA was 2.4 years
(range, 0.8–3.6 years). A limitation of hip motion (ran-
ging between 10 and 30°) was identified in eight patients.
Average flexion was 91.1° (range, 35–130°). Elevation of
both C-reactive protein (CRP) and erythrocyte sedimen-
tation rate (ESR) was identified in two patients. The
serum white blood count, CRP, and ESR were normal in
the other 17 patients.
Radiographs showed the typical characteristics of
end-stage PVNS of the hip including cystic erosions and
joint space narrowing (Fig. 1). Eight patients had the
nearly complete disappearance of the joint space. Seven
patients underwent preoperative magnetic resonance
imaging, which showed the characteristic low signal
intensity on the T2-weighted sequences and blooming
artifact from the high hemosiderin on the gradient-echo
sequences.
Surgical treatment
An institutional standard protocol for total hip
arthroplasty was performed for all cases by experienced
arthroplasty surgeons. A posterolateral approach was
utilized for all patients within the study. For patients
with PVNS, complete radical excision of the diseased
synovium was performed and pathologic synovial tissues
were submitted for histologic evaluation. Removal of the
femoral head and neck provided enough space between
the pelvis and the femur for a synovectomy. The tissue
contained within the cystic areas of the acetabulum and
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the femur was carefully removed. Cementless implants
using ceramic-on-ceramic bearings were inserted in all
patients. Pinnacle® (DePuy, Warsaw, IN, USA) or
Betacup®/Combicup® (Link, Hamburg, Germany) were
used for cup components, while Corail® (DePuy,
Warsaw, IN, USA) or Ribbed®/LCU® Link Classic Unce-
mented (Link, Hamburg, Germany) were used for stem
components.
The postoperative protocol included a drainage tube
and prophylactic administration of antibiotics for 24 h.
The patients were allowed partial weight-bearing with a
walking aid after a postoperative radiographic evaluation
on the first postoperative day, and then were allowed full
weight-bearing at 6–8 weeks. The duration of prophy-
laxis for deep vein thrombosis was for 30 days.
Clinical and radiologic evaluation
Hip function was evaluated using Harris Hip Scores
(HHS) before THA and at the last follow-up of each pa-
tient [16]. Questionnaire responses regarding the need
for walking aids and the ability to perform moderate and
strenuous activities were also recorded. Radiographic
loosening was defined in accordance with previously
published studies: a loose acetabular component was de-
fined if the cup had ≥ 2 mm migration, ≥ 5° changes in
tilting, shedding of metal particles, or a continuous
radiolucent line across all zones, as described by Delee
and Charnley [17, 18]; a loose femoral stem was charac-
terized by ≥ 5 mm progressive subsidence, pedestal for-
mation, the shedding of metal particles, or a continuous
radiolucent line around the stem, as defined by Gruen et
al. [19]. Periprosthetic osteolysis was determined to be
present if there were periprosthetic lesions ≥ 2 mm in
diameter on follow-up radiographs [20]. Local recurrence
of PVNS was determined by a series of radiological
changes in adjacent bone (e.g., cystic erosions without cal-
cification or sclerosis, demineralization of surrounding
bone) [21]. All radiologic evaluations were performed by
two experienced orthopedic surgeons. Complications re-
lated to CoC THA included infection, dislocation, squeak-
ing, or ceramic fracture were recorded.
Statistical analysis
Categorical variables were presented as frequencies and
percentages, and continuous variables as means and
standard deviations. The clinical characteristics between
groups were compared with the use of the independent t
test or the Mann-Whitney test for continuous variables
and the chi-squared test or Fisher’s exact test for
categorical variables. A Kaplan-Meier implant survival
curve was generated with 95% confidence intervals (CI)
at 10 years. The end point was set at the any-cause
revision of CoC THA (e.g., aseptic loosening, infection,
osteolysis, recurrent dislocation, ceramic fracture, or
Table 1 The patients with pigmented villonodular synovitis of the hip
Case Age Gender Duration of
symptoms (years)
Surgery before THA Cup Stem FU (years) Complications
1 28 Male 1 N/A Pinnacle Corail 8.6 –
2 26 Female 1.3 N/A Betacup Corail 9.3 Aseptic loosening
3 39 Female 2.4 N/A Combicup Ribbed 7.6 –
4 35 Female 3 Arthroscopic synovectomy Pinnacle Corail 8.8 –
5 53 Male 2.7 N/A Betacup Ribbed 10.6 –
6 24 Female 2 N/A Combicup Ribbed 8.5 –
7 40 Male 2.3 Internal fixation Betacup Ribbed 10.3 Squeaking
8 48 Female 2 N/A Pinnacle Corail 7.4 –
9 26 Male 4 N/A Betacup Ribbed 7.9 –
10 30 Female 6.2 N/A Betacup LCU 7.7 –
11 32 Female 3.8 Arthroscopic synovectomy Pinnacle Corail 8.3 –
12 58 Female 2.5 N/A Pinnacle Corail 7.7 –
13 28 Female 3 N/A Combicup LCU 6.9 –
14 47 Male 1.2 N/A Combicup Ribbed 10.8 –
15 35 Male 4.2 N/A Pinnacle Corail 7.9 –
16 22 Female 1.8 Arthroscopic synovectomy Pinnacle Corail 9.1 –
17 29 Female 2.8 Arthroscopic synovectomy Betacup LCU 9.7 –
18 37 Female 4.3 N/A Betacup LCU 7.8 –
19 31 Male 4 Arthroscopic synovectomy Combicup LCU 9.5 –
THA total hip arthroplasty, LCU link classic uncemented, FU follow-up, N/A not applicable
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Fig. 1 The typical appearance of PVNS as seen in radiography of the hip, magnetic resonance imaging (MRI), and computed tomography (CT).
Anteroposterior radiograph of case 5 (a) and lateral radiograph of the case 16 (b) show erosions and cysts in both the femoral head and the
acetabulum of left hip with nearly complete obliteration of the joint space. CT (c) and MRI (d) of case 14 show the characteristic cyst-like
structure of the femoral head
Table 2 Patient characteristics and follow-up between the PVNS group and the control group
PVNS (n = 19) Controls (n = 38) p value
Age (year), mean ± SD 35.2 ± 10.2 35.2 ± 10.0 1.000
Gender, n (%) 1.000
Female 12 (63.2%) 24 (63.2%)
Male 7 (36.8%) 14 (36.8%)
Body mass index (kg/m2), mean ± SD 24.6 ± 2.2 24.5 ± 1.9 0.975
American Society of Anesthesiologists score 1.000
1 14 28
2 4 8
3 1 2
Diagnosis, n (%) –
Osteonecrosis 0 (0%) 27 (71%)
Osteoarthritis 0 (0%) 11 (29%)
PVNS 19 (100%) 0 (0%)
Follow-up (years), mean ± SD 8.7 ± 1.3 8.6 ± 1.1 0.902
PVNS pigmented villonodular synovitis, SD standard deviation
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squeaking). A p value of < 0.05 was considered signifi-
cant. All of the statistical analyses were performed with
the statistical software packages R (http://www.R-projec-
t.org, The R Foundation) and EmpowerStats (http://
www.empowerstats.com, X&Y Solution, Inc., Boston,
MA).
Results
Cohort and specimen characteristics
Due to strict matching, the age, sex, BMI, and ASA
scores were similar between the two groups (Table 2).
Of the 38 controls, 27 were patients with osteonecrosis
of the femoral head while 11 were diagnosed with
osteoarthritis of the hip. The mean follow-up for the
PVNS and the control group was 8.6 ± 1.1 years and 8.7
± 1.3 years, respectively. The diagnosis of PVNS was
made by pathological examination of all 19 patients.
Macroscopically, the pathologic synovial tissues were
brown or yellowish. Histologically, there were numerous
synovial cell and multinucleated giant cells (Fig. 2).
Hemosiderin-laden macrophages were found in 13 of 19
patients. We did not identify any malignant changes or
atypical cytology.
PVNS and outcomes following THA
The outcomes following cementless CoC THA between
groups are presented in Table 3. At the most recent
follow-up, there were no clinical or radiological signs of
osteolysis or loosing after CoC THA in PVNS patients,
which indicated no recurrence of PVNS (Fig. 3). The
results of radiologic evaluations by the two different
surgeons were consistent. There was no significant
difference between the PVNS group and the control
group for HHS scores prior to the THA and at the most
recent follow-up. In the PVNS group, the mean HHS
improved from 48.7 (range 39–62) points preoperatively
to 92.6 (range 81–99) at the last follow-up, and was
statistically significant (P < 0.001). All patients could
perform moderate physical activities without crutches,
and five patients could perform strenuous activities
regularly, including running, sports, and climbing.
One patient (case 2) underwent revision due to aseptic
loosening in the PVNS group, while another patient
(case 7) developed a squeaking complication 2 years
postoperatively, but did not require revision. In the con-
trol group, two patients underwent revision (one aseptic
revision and one infection) (p = 1.000). For the patient
who underwent aseptic revision in the PVNS group, no
pathological evidence of recurrence of PVNS was found
by histological examination. None of the patients experi-
ence osteolysis, dislocation, or ceramic fracture in either
group. The implant survivorship free of any revision was
Fig. 2 A photomicrograph of case 14 showing synovial hypertrophy
and histiocyte proliferation with multinucleated giant cells.
(hematoxylin and eosin, original magnification × 200)
Table 3 The outcomes following cementless ceramic-on-
ceramic total hip arthroplasty between the PVNS group and the
control group
PVNS (n = 19) Controls (n = 38) p value
Mean HHS, point, SD
Preoperative 48.7 ± 3.8 48.2 ± 4.1 0.612
Latest follow-up 92.6 ± 5.5 93.4 ± 4.6 0.584
Aseptic loosening, n (%) 1 (5.3%) 1 (2.6%) 0.614
Infection, n (%) 0 (0%) 1 (2.6%) 0.480
Osteolysis, n (%) 0 (0%) 0 (0%) –
Dislocation, n (%) 0 (0%) 0 (0%) –
Ceramic fracture, n (%) 0 (0%) 0 (0%) –
Squeaking, n (%) 1 (5.3%) 0 (0%) –
Any revision, n (%) 1 (5.3%) 2 (5.3%) 1.000
PVNS pigmented villonodular synovitis, HHS Harris Hip Score, SD
standard deviation
Fig. 3 A radiograph was taken 9.1 years after THA showed well-fixed
prosthesis (case 16)
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90.0% (95% CI, 73.2% to 100%) in the PVNS group and
92.5% (95% CI, 82.6% to 100%) in the control group at
10 years (p = 0.99) (Fig. 4).
Discussion
This study demonstrated that patients with PVNS
undergoing cementless CoC THA had similar survivor-
ship and functionality compared to those with the diag-
nosis of osteonecrosis of femoral heads or osteoarthritis
of hips. None of the patients with PVNS experienced in-
fection, osteolysis, dislocation, or ceramic fracture after a
mean follow-up of 8.6 years. Moreover, there was no evi-
dence of recurrent PVNS during the middle-term
follow-up in the present study.
PVNS is a proliferative disorder characterized by infil-
tration of hemosiderin-laden macrophages, multinucle-
ated giant cells, and inflammatory cells which carry a
high risk of recurrence [22–24]. Due to its low inci-
dence, PVNS is not well understood. While a consensus
regarding the pathogenesis of PVNS has not yet been
established, some researchers have hypothesized that
trauma-induced hemorrhage could be a causative fac-
tor [25, 26]; in previously published case series, prior
trauma ranged from 3 to 53% [27] In our study, 4 of
19 patients with PVNS (21.1%) had had a history of
hip trauma before the diagnosis of PVNS. Although
other researchers suggested patients with PVNS com-
monly have abnormal serum inflammation markers
[28], there were only two patients with PVNS (10.5%)
with elevated ESR and CRP in our study. However,
our results correspond to those reported by Gitelis et
al. who initially documented a lack of an inflamma-
tory syndrome associated with PVNS [27].
Despite improved imaging, definitive preoperative
diagnosis of PVNS is difficult without histopathology. At
the early stage of PVNS, the treatment primarily in-
cludes either open or arthroscopic synovectomy. How-
ever, PVNS has a high recurrence rate, up to 25%, likely
due to incomplete debridement without neck cutting [2].
In the present study, five patients with PVNS had under-
gone previous arthroscopic synovectomy; the duration
between the last synovectomy and the primary THA
were 0.8, 2, 2.5, 3.1, and 3.6 years (mean 2.4 years). We
hypothesize that the short-term recurrence may be re-
lated to incomplete synovectomy by arthroscopy
technique.
At end-stage PVNS, THA is the most effective treat-
ment option, with lower PVNS recurrence rates and
Fig. 4 A Kaplan-Meier implant survivorship curve of patients with and without PVNS
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lower revision rates than synovectomy alone [8]. The
lifespan of the primary THA is of significant concern, as
patients with PVNS are typically younger and will there-
fore retain the implants for a longer duration of time.
The two most important aspects of implant longevity
are the method of implant fixation and the type of
bearing surface [14]. While case studies of PVNS of the
hip are limited, both cemented and cementless THA
have been reported to result in good outcomes [14].
No recurrent PVNS was found during the follow-up
in the present study, which is similar to prior studies
[5, 7, 13, 14]. Yoo et al. [5] reported eight PVNS pa-
tients with cementless THA and none of the patients had
clinical or radiographic evidence of recurrent PVNS for an
average of 8.9 years follow-up. Recently, Tibbo et al. [7]
reviewed 25 patients PVNS who underwent THA with
conventional polyethylene or highly crosslinked polyethyl-
ene bearings during a mean of 10 years follow-up. Of
them, only one patient (4%, 1/25) occurred recurrence at
24 years postoperatively.
Of the studies involving cementless THAs, most of the
studies, however, only reported on polyethylene or metal
bearing surfaces [5, 7, 14, 27]. Hoberg et al. [29] reported
two cases of metal-on-metal hip resurfacing in patients
with PVNS. Yoo et al. [6] described revisions due to pros-
thesis loosening and osteolysis in two of eight patients
who had undergone THA using metal-non-cross-linked
polyethylene bearing and periprosthetic osteolysis;
additionally, two other patients had loosening with
zirconia-non-cross-linked polyethylene. The need for
revisions and the shorter implant survivorship in these
cases is thought to be due to conventional polyethylene
induced-wear and metal ion-induced osteolysis resulting
in aseptic loosening [28, 29]. Recently, Tibbo et al.
reported the 10-year survivorship free from any revision
was 100% for highly crosslinked polyethylene liners and
66% for conventional polyethylene liners [8]. The
Ceramic-on-ceramic bearing surface, characterized by its
superior hardness and smoothness, has the lowest wear
rates in comparison to all other bearing surfaces in THA
[30, 31]. In our study, only one patient underwent a revi-
sion arthroplasty due to aseptic loosening. The 10-year
implant survivorship free of any revision after CoC THA
was 90.0% in the PVNS group, which was similar to that
in the control group (92.5%, p = 0.99). Moreover, we did
not identify any local recurrence in the PVNS cohort.
There are several limitations in our study. A major
limitation was the retrospective case-control design of
the study, which is subject to inherent biases of the de-
sign. Additionally, we did not sort the disease manifesta-
tions (diffuse vs. focal) based on pathological
classification, although all cases were diagnosed by histo-
logical evaluations. Another limitation is that we cannot
compare outcomes of different bearing surfaces, such as
metal-on-metal, metal-on-polyethylene, or ceramic-on-
polyethylene articulation, as PVNS patients in this study
were all treated with CoC THA.
Conclusions
In conclusion, end-stage PVNS of hip treated with
cementless CoC THA had a low complication rate with
similar implant survivorship and restoration of function in
comparison to other young patients with osteonecrosis or
osteoarthritis. These findings indicate that utilization of
cementless THA ceramic-on-ceramic bearings could be a
viable option for young patients with PVNS.
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